Cardlytics Inc. (CDLX)
| Bid | 1.81 |
| Market Cap | 94.5M |
| Revenue (ttm) | 272.59M |
| Net Income (ttm) | -178.31M |
| EPS (ttm) | -3.57 |
| PE Ratio (ttm) | -0.5 |
| Forward PE | -1.43 |
| Analyst | Hold |
| Ask | 1.96 |
| Volume | 283,549 |
| Avg. Volume (20D) | 1,081,493 |
| Open | 1.85 |
| Previous Close | 1.86 |
| Day's Range | 1.78 - 1.86 |
| 52-Week Range | 1.22 - 9.78 |
| Beta | 1.31 |
About CDLX
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for CDLX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
5 days ago · seekingalpha.com
Cardlytics: Underrecognized Margin Recovery; Strong Buy ReiteratedWe maintain our Strong Buy on Cardlytics and issue a PT of $6, despite the near-term revenue reset and slower monetization from new partners. The Amex channel is a game-changer, offering high-margin, ...
1 month ago · businesswire.com
Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)ATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that on April 24, 2025, the Compensation Committee of Cardlytics' Board of Directors granted an aggregate of 124,050 restricte...
1 month ago · businesswire.com
Cardlytics Announces Timing of Its First Quarter 2025 Earnings ReleaseATLANTA--(BUSINESS WIRE)--Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the first quarter ending March 31, 2025 will be released on May 7, 2025, after market close. Co...
2 months ago · businesswire.com
Law Offices of Frank R. Cruz Encourages Cardlytics, Inc. (CDLX) Investors To Inquire About Securities Fraud Class ActionLOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Encourages Cardlytics, Inc. (CDLX) Investors To Inquire About Securities Fraud Class Action.
